Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.
NCT03744585
·
clinicaltrials.gov ↗
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Cell Carcinoma
Sponsor
Ipsen